id stringlengths 40 40 | source stringclasses 9
values | title stringlengths 2 345 | clean_text stringlengths 35 1.63M | raw_text stringlengths 4 1.63M | url stringlengths 4 498 | overview stringlengths 0 10k |
|---|---|---|---|---|---|---|
bdbf8aa67c0cfd240ceb9d62a8e8192697dd2406 | who | None | The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to and determine whether revisions to the fifth edition of the Medical eligibility criteria for contraceptive use... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
e9af3ce80af30b23054e04f33b447aa59ddbf8c7 | who | None | Sexually transmitted infections (STIs) are a major public health problem worldwide, affecting quality of life and causing serious morbidity and mortality. STIs have a direct impact on reproductive and child health through infertility, cancers and pregnancy complications, and they have an indirect impact through their r... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
24593a9a6d8771492e5fea603b7dd6c2a0d11218 | who | None | This Web Annex provides detailed information on the processes, procedures and methods for developing Guidelines on the management of chronic pain in children. These guidelines were developed according to World Health Organization (WHO) guidance on guideline development: WHO handbook for guideline development (2 nd edit... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
560faaaab4932c1cf74fc45ef78046a60b830875 | who | None | Various organizations were represented in the process by observers who provided valuable comments, including France Donnay (Bill & Melinda Gates Foundation); Deborah#
# Executive summary
The days and weeks following childbirth -the postnatal period -is a critical phase in the lives of mothers and newborn babies. Most... | Various organizations were represented in the process by observers who provided valuable comments, including France Donnay (Bill & Melinda Gates Foundation); Deborah# •
# Executive summary
The days and weeks following childbirth -the postnatal period -is a critical phase in the lives of mothers and newborn babies. Mos... | None | None |
53d6097a1efca7e0f51a74dcedebffa59f08ef4f | who | None | # Long-acting injectable cabotegravir (CAB-LA)
Long-acting injectable cabotegravir (CAB-LA) is an integrase strand-transfer inhibitor (INSTI).
It is given to people who do not have HIV infection, at a dose of 600 mg, intramuscularly, four weeks apart for the first two injections and every eight weeks thereafter for the... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
de22b34701360dcb7a711946fc806b8f9de7d965 | who | None | # INTRODUCTION 11
This document is the first step in the provision by the World Health Organization (WHO) of comprehensive guidance on viral hepatitis surveillance, prevention and treatment. It provides recommendations on the prevention of viral hepatitis B (HBV) and viral hepatitis C (HCV). The recommendations are bas... | # INTRODUCTION 11
# iNTROdUCTiON
This document is the first step in the provision by the World Health Organization (WHO) of comprehensive guidance on viral hepatitis surveillance, prevention and treatment. It provides recommendations on the prevention of viral hepatitis B (HBV) and viral hepatitis C (HCV). The recomme... | None | None |
e60cd3030a90c046c9095ada04a65531bb7fdcc2 | who | None | Introduction of a DTG-based regimen for children older than six years appears to be feasible, especially given the possibility of using a simplified dosing approach with a 50-mg generic DTG formulation from at least 25 kg.
Treating neonates requires early infant diagnosis and linkage to care in the first four weeks of ... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
632abc00ecfae6a463c3dbb51d350a809272e605 | who | None | # Executive summary Introduction
The postnatal period, defined here as the period beginning immediately after the birth of the baby and extending up to six weeks (42 days), is a critical time for women, newborns, partners, parents, caregivers and families. Yet, during this period, the burden of maternal and neonatal mo... | # Executive summary Introduction
The postnatal period, defined here as the period beginning immediately after the birth of the baby and extending up to six weeks (42 days), is a critical time for women, newborns, partners, parents, caregivers and families. Yet, during this period, the burden of maternal and neonatal mo... | None | None |
d99c3f5c3350ab27b1889eee05f035e7acb40d5b | who | None | # Zinc supplementation in pregnancy
Zinc is a trace element found in many foods, particularly in meat, but also in dairy products, legumes and unrefined cereals; diets low in bioavailable zinc are those in which animal protein is low and intake of cereals is high (1). Zinc is not stored in the body, so physiological ne... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is n... | None | None |
c7f8101f9305f36a6a4369b5a0bd77445285df8f | who | None | This statement is based on scientific reviews prepared for a Flour Fortification Initiative (FFI) technical workshop held in Stone Mountain, GA, USA in 2008 where various organizations actively engaged in the prevention and control of vitamin and mineral deficiencies and various other relevant stakeholders met and disc... | This statement is based on scientific reviews prepared for a Flour Fortification Initiative (FFI) technical workshop held in Stone Mountain, GA, USA in 2008 where various organizations actively engaged in the prevention and control of vitamin and mineral deficiencies and various other relevant stakeholders met and disc... | None | None |
3ad1096d2196666490591516c4f00a21ad22a12f | who | None | - Diagnostic testing for SARS-CoV-2 is a critical component to the overall prevention and control strategy for COVID-19. - Tests should be reliable, affordable, accessible and provide results rapidly to ensure appropriate clinical care and support for patients and inform actions to prevent onward spread of SARS-CoV-2. ... | #
• Diagnostic testing for SARS-CoV-2 is a critical component to the overall prevention and control strategy for COVID-19. • Tests should be reliable, affordable, accessible and provide results rapidly to ensure appropriate clinical care and support for patients and inform actions to prevent onward spread of SARS-CoV-... | None | None |
de78cef59a6dc11ffbbb181b99e5bb4426d04bec | who | None | During the training you receive, your facilitator will explain to you how to use this logbook. It will be your companion throughout the course and after, and has been designed to be an interactive and dynamic document, to facilitate further development of your attitude, knowledge and skills in providing care to people ... | Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any speci c organization, products or services. The use of the WHO logo is no... | None | None |
0adae83bccfa54c992da0823dc5c065190c78271 | wikidoc | Drug-Eluting Stent Thrombosis More Than Seven Years After Implantation: Pathophysiology of “Very” Very Late Stent Thrombosis Elucidated by Optical Coherence Tomography and Histological Analysis | Drug-Eluting Stent Thrombosis More Than Seven Years After Implantation: Pathophysiology of “Very” Very Late Stent Thrombosis Elucidated by Optical Coherence Tomography and Histological Analysis
# Authors
Alec Vishnevsky, MD (@AVishnevsky_MD)1; Antony Kaliyadan, MD1; David L. Fischman, MD (@fischman_david)1; Nicholas J... | Drug-Eluting Stent Thrombosis More Than Seven Years After Implantation: Pathophysiology of “Very” Very Late Stent Thrombosis Elucidated by Optical Coherence Tomography and Histological Analysis
Click here to go back to the Tweetbook
Click here to read more about stent thrombosis
# Authors
Alec Vishnevsky, MD (@AVishn... | https://www.wikidoc.org/index.php/Drug-Eluting_Stent_Thrombosis_More_Than_Seven_Years_After_Implantation:_Pathophysiology_of_%E2%80%9CVery%E2%80%9D_Very_Late_Stent_Thrombosis_Elucidated_by_Optical_Coherence_Tomography_and_Histological_Analysis | |
fa74fb7baf4a5c51be0dac09d01df9552045a5cb | wikidoc | HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study | HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study
September 2, 2008 by Leah H. Biller
ESC Congress 2008- Munich, Germany: Investigators from Italy reported that for poor responders to stan... | HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study
September 2, 2008 by Leah H. Biller [1]
ESC Congress 2008- Munich, Germany: Investigators from Italy reported that for poor responders to ... | https://www.wikidoc.org/index.php/HDB_Tirofiban_decreases_rate_of_periprocedural_myocardial_infarction_compared_to_placebo_in_patients_with_poor_responsiveness_to_clopidogrel_and_aspirin:_Results_of_the_3T/2R_study | |
c4279533ff5497125f295e3607b18753f8007a57 | wikidoc | Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial | Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial
September 1, 2008 by Leah H. Biller
ESC Congress 2008- Munich, Germany: European investigators reported that for diabetes patients with coronary... | Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial
September 1, 2008 by Leah H. Biller [1]
ESC Congress 2008- Munich, Germany: European investigators reported that for diabetes patients with coro... | https://www.wikidoc.org/index.php/Revascularization_with_CABG_or_PCI_had_no_Difference_on_Outcomes_of_Death,_non-fatal_MI,_or_CVA_for_Diabetics_with_Multi-Vessel_Coronary_Disease:_Results_of_the_CARDia_Trial | |
78d6fef18411a956d111ea8a00ad803de25cb278 | wikidoc | Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial | Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial
# Official Title
Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Random... | Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Twinkle Singh, M.B.B.S. [2]
# Official Title
Safety and Efficacy of a D-Di... | https://www.wikidoc.org/index.php/Safety_and_Efficacy_of_a_D-Dimer-Guided_Strategy_for_Extension_of_Secondary_Prophylaxis_of_Venous_Thromboembolism_-_a_Prospective_and_Randomized_Management_Trial | |
5c5b6451a2e23c2926194cc17549913f11bd62ee | wikidoc | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
1. During the first 48 h after onset of AF, the need for anticoagulation before and after cardioversion may be based on the patient’s ... | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a lic... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Prevention_of_thromboembolism_in_patients_with_atrial_fibrillation_undergoing_cardioversion:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
81b0a8a3e3be23bb53bead1c2195bc649530003b | wikidoc | Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study | Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study
September 3, 2009 By Alexandra M. Palmer
Barcelona, Spain: Results from the Study of PLATelet Inhibition and Patient Outcomes (PLATO) indicate that treatment ... | Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study
September 3, 2009 By Alexandra M. Palmer [1]
Barcelona, Spain: Results from the Study of PLATelet Inhibition and Patient Outcomes (PLATO) indicate that treatm... | https://www.wikidoc.org/index.php/Ticagrelor_is_superior_to_Clopidogrel_in_the_treatment_of_patients_with_acute_coronary_syndrome_with_or_without_ST-segment_elevation:_Results_of_the_PLATO_study | |
6e929c0f833a5932471e77d720e1f2cf8a1d2c01 | wikidoc | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- For patients with AF of 48-h duration or longer, or when the duration of AF is unknown, anticoagulation (INR 2.0 to 3.0) is recommended ... | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licen... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Prevention_of_thromboembolism_in_patients_with_atrial_fibrillation_undergoing_cardioversion:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
b888c38d5ec59dfcad32edbea82304a997b6eb19 | wikidoc | Percutaneous Transluminal Coronary Angioplasty of a Left Main Chronic Total Occlusion in a Retrograde Approach via a Saphenous Vein Graft with Impella Support | Percutaneous Transluminal Coronary Angioplasty of a Left Main Chronic Total Occlusion in a Retrograde Approach via a Saphenous Vein Graft with Impella Support
# Authors
Jonathan S. Gordin, MD (@JonGordin)1; Ravi H. Dave, MD (@RaviDaveMD1)2; William M. Suh, MD (@willsuh76)2
1From Division of Cardiology, David Geffen Sc... | Percutaneous Transluminal Coronary Angioplasty of a Left Main Chronic Total Occlusion in a Retrograde Approach via a Saphenous Vein Graft with Impella Support
Click here to go back to the Tweetbook
Click here to read more about chronic total occlusion
Click here to read more about impella
# Authors
Jonathan S. Gordin... | https://www.wikidoc.org/index.php/Percutaneous_Transluminal_Coronary_Angioplasty_of_a_Left_Main_Chronic_Total_Occlusion_in_a_Retrograde_Approach_via_a_Saphenous_Vein_Graft_with_Impella_Support | |
16a0df3568086bb44d19a008a48a8dc3a960a55f | wikidoc | The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study | The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study
# Official Title
The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospecti... | The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Twinkle Singh, M.B.B.S. [2]
# Official Title
The Negative Predictive Value of... | https://www.wikidoc.org/index.php/The_Negative_Predictive_Value_of_D-dimer_on_the_Risk_of_Recurrent_Venous_Thromboembolism_in_Patients_With_Multiple_Previous_Events:_a_Prospective_Cohort_Study | |
bb1a5a816dddb940d7da70986c26c0d062e47ab2 | wikidoc | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. During the first 48 h after onset of AF, the need for anticoagulation before and after cardioversion may be based on the patient’s risk ... | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Prevention_of_thromboembolism_in_patients_with_atrial_fibrillation_undergoing_cardioversion:_Polling_Results_for_CLASS_IIa_Guidelines | |
7b23f8caaceab5c27086de4c4d91b56915039e73 | wikidoc | A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients | A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
# Official Title
A phase 2a, multi-center, randomized, double-blind, placebo-controlled, single ascending dose study to investigate the safety, tolerability and pha... | A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Official Title
A phase 2a, multi-center, randomized, double-blind, placebo-controlled, single ascending dose s... | https://www.wikidoc.org/index.php/A_Single_Ascending_Dose_Study_Examining_the_Safety_and_Pharmacokinetic_Profile_of_Reconstituted_High_Density_Lipoprotein_(CSL112)_Administered_to_Patients | |
0bed4500ef49bc5dd3255614218234b0c1ead782 | wikidoc | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS I Guidelines | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. For patients with AF of 48-h duration or longer, or when the duration of AF is unknown, anticoagulation (INR 2.0 to 3.0) is recommended for ... | The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed h... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Prevention_of_thromboembolism_in_patients_with_atrial_fibrillation_undergoing_cardioversion:_Polling_Results_for_CLASS_I_Guidelines | |
27d809d0085540e633a23aada5e745ffe243aed2 | wikidoc | Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry | Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry
March 31, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Results from the MATRIX Registry, a large community-based registry consisting of patients who were treated with dr... | Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry
March 31, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Results from the MATRIX Registry, a large community-based registry consisting of patients who were treated with d... | https://www.wikidoc.org/index.php/Long_Term_Adherence_to_Clopidogrel_and_Late_Adverse_Cardiac_Events_after_Off-Label_Use_of_Sirolimus-Eluting_Stents:_Results_of_the_MATRIX_Registry | |
053d95d908cedac92fda08df0c2b043f5e120131 | wikidoc | ICD-10 Chapter II: Neoplasms; Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism | ICD-10 Chapter II: Neoplasms; Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism
# C00-D48 - Neoplasms
## (C00-C14) Malignant neoplasms, lip, oral cavity and pharynx
- (C00) Malignant neoplasm of lip
- (C01) Malignant neoplasm of base of tongue
- (C02) Ma... | ICD-10 Chapter II: Neoplasms; Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism
# C00-D48 - Neoplasms
## (C00-C14) Malignant neoplasms, lip, oral cavity and pharynx
- (C00) Malignant neoplasm of lip
- (C01) Malignant neoplasm of base of tongue
- (C02) Ma... | https://www.wikidoc.org/index.php/ICD-10_Chapter_C | |
4384ff99ae93495f0f3913455dd78e52f4743e26 | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS III Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS III Guidelines
# Class III Guidelines
- Frequent repetition of direct-current cardioversion is not recommended for patients who have relatively short periods of sinus rhythm between relapses of... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare prov... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Suggest_Revisions_to_the_CLASS_III_Guidelines | |
b63c24b27bf7ee2fdc216e3c93e59200dafd4f4a | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- Direct-current cardioversion can be useful to restore sinus rhythm as part of a long-term management strategy for patients with AF. (Level of Evidence: B... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare prov... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
abf6992e7bf39d1b0ec2a264fa6fd4affb3c64b7 | wikidoc | High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study | High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study
September 2, 2008 by Leah H. Biller
ESC Congress 2008- Munich, Germany: Investigators from Italy reported that for poor responders to standard oral antiplatelet agents, treatment ... | High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study
September 2, 2008 by Leah H. Biller [1]
ESC Congress 2008- Munich, Germany: Investigators from Italy reported that for poor responders to standard oral antiplatelet agents, treatm... | https://www.wikidoc.org/index.php/High_dose_Tirofiban_Might_be_Beneficial_among_Poor_Responders_to_Clopidogrel_and_Aspirin_Following_Elective_PCI:_Results_of_the_3T/2R_study | |
dd741abe0641377e07a35371222974b0a9dfeb6e | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- When a rapid ventricular response does not respond promptly to pharmacological measures for patients with AF with ongoing myocardial ischemia, symptomatic hy... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provid... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
353fd2f8a1729fe020486db1996a3af26d7df901 | wikidoc | Thrombus Aspiration is Associated with Improved 1 Year Mortality Rates in STEMI Patients: the Results of the 1 Year TAPAS Follow-Up Study | Thrombus Aspiration is Associated with Improved 1 Year Mortality Rates in STEMI Patients: the Results of the 1 Year TAPAS Follow-Up Study
June 6, 2008 by Scott P. Williams , Leah H. Biller
Groningen, Netherlands: Investigators from University Medical Centre Groningen published a 1 year follow-up of The Thrombus Aspira... | Thrombus Aspiration is Associated with Improved 1 Year Mortality Rates in STEMI Patients: the Results of the 1 Year TAPAS Follow-Up Study
June 6, 2008 by Scott P. Williams [1], Leah H. Biller [2]
Groningen, Netherlands: Investigators from University Medical Centre Groningen published a 1 year follow-up of The Thrombus... | https://www.wikidoc.org/index.php/Thrombus_Aspiration_is_Associated_with_Improved_1_Year_Mortality_Rates_in_STEMI_Patients:_the_Results_of_the_1_Year_TAPAS_Follow-Up_Study | |
ffa468dbf01494638bb2e221de41b8d58e4d3617 | wikidoc | Class III recommendations in guidelines for cardiovascular medicine list of guidelines organization by level of evidence - Unclassified | Class III recommendations in guidelines for cardiovascular medicine list of guidelines organization by level of evidence - Unclassified
# Overview
# Class III Recommendations with Unclassified Level of Evidence: Organized by Guideline Keywords
# Class III Recommendations with Unclassified Level of Evidence: Organize... | Class III recommendations in guidelines for cardiovascular medicine list of guidelines organization by level of evidence - Unclassified
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
# Class III Recommendations with Uncl... | https://www.wikidoc.org/index.php/Class_III_recommendations_in_guidelines_for_cardiovascular_medicine_list_of_guidelines_organization_by_level_of_evidence_-_Unclassified | |
54d986637d47c25d90e549c35662473fbd5eedbd | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS III Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS III Guidelines
# Class III Guidelines
1. Frequent repetition of direct-current cardioversion is not recommended for patients who have relatively short periods of sinus rhythm between relapses of AF ... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider.... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Polling_Results_for_CLASS_III_Guidelines | |
c916bc7b9aff6e75fd56a9d742c5532f847b69aa | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Direct-current cardioversion can be useful to restore sinus rhythm as part of a long-term management strategy for patients with AF. (Level of Evidence: B)
A... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider.... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Polling_Results_for_CLASS_IIa_Guidelines | |
678170030f68e3459833680479c45b5057b5b6f3 | wikidoc | Endoscopic versus Open Harvesting of Saphenous Vein Grafts: Secondary PREVENT IV analysis published in New England Journal of Medicine | Endoscopic versus Open Harvesting of Saphenous Vein Grafts: Secondary PREVENT IV analysis published in New England Journal of Medicine
July 16, 2009: Among patients undergoing coronary artery bypass surgery (CABG), endoscopic vein-graft harvesting was associated with higher rates of vein graft failure and adverse clini... | Endoscopic versus Open Harvesting of Saphenous Vein Grafts: Secondary PREVENT IV analysis published in New England Journal of Medicine
July 16, 2009: Among patients undergoing coronary artery bypass surgery (CABG), endoscopic vein-graft harvesting was associated with higher rates of vein graft failure and adverse clin... | https://www.wikidoc.org/index.php/Endoscopic_versus_Open_Harvesting_of_Saphenous_Vein_Grafts:_Secondary_PREVENT_IV_analysis_published_in_New_England_Journal_of_Medicine | |
ac6febeff8cf7d93942796834c8a1298033d7559 | wikidoc | The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients | The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
August 31, 2008 by Leah H. Biller
ESC Congress 2008- Munich, Germany: The GISSI-HF study demonstrates that among chronic heart failure patients, treatment with n-3 polyunsaturated fatty... | The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
August 31, 2008 by Leah H. Biller [1]
ESC Congress 2008- Munich, Germany: The GISSI-HF study demonstrates that among chronic heart failure patients, treatment with n-3 polyunsaturated f... | https://www.wikidoc.org/index.php/The_GISSI-HF_trial_suggests_long-term_treatment_with_n-3_PUFAs_provides_moderate_clinical_benefits_for_chronic_heart_failure_patients | |
f298b7033eef8e1f5910976e8952c110aa2e99ff | wikidoc | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS I Guidelines | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. When a rapid ventricular response does not respond promptly to pharmacological measures for patients with AF with ongoing myocardial ischemia, symptomatic hypote... | The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. P... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Direct-current_cardioversion_of_atrial_fibrillation_and_atrial_flutter:_Polling_Results_for_CLASS_I_Guidelines | |
ab25fde3d5d625c37cc03df1377d8489802d6420 | wikidoc | Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update | Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
# 2011 AHA/ACC Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease
## Smoking
## Blood pressure control
## Lipid manage... | Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# 2011 AHA/ACC Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease[1]
... | https://www.wikidoc.org/index.php/Secondary_Prevention_and_Risk_Reduction_Therapy_for_Patients_With_Coronary_and_Other_Atherosclerotic_Vascular_Disease:_2011_Update | |
73ec84846ba9836410d87fd8f8f75057502de61b | wikidoc | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- Pretreatment with amiodarone, flecainide, ibutilide, propafenone, or sotalol can be useful to enhance the success of direct-current cardioversion and prevent recurr... | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Pleas... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_enhancement_of_direct-current_cardioversion:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
a022cf929831bcb0a2ab59a8884521468f21db1e | wikidoc | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIb Guidelines | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIb Guidelines
# Class IIb Guidelines
- For patients with persistent AF, administration of beta blockers, disopyramide, diltiazem, dofetilide, procainamide, or verapamil may be considered, although the ef... | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Pleas... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_enhancement_of_direct-current_cardioversion:_Suggest_Revisions_to_the_CLASS_IIb_Guidelines | |
1af3476a49275f882bcb03e46dca5c9e59c9fe25 | wikidoc | The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS IIa Guidelines | The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS IIa Guidelines
1- A strategy of coronary angiography with intent to perform PCI (or emergency CABG) is reasonable in patients ≥75 years of age who have received fibrinolytic therapy, and are in cardiogenic s... | The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS IIa Guidelines
1- A strategy of coronary angiography with intent to perform PCI (or emergency CABG) is reasonable in patients ≥75 years of age who have received fibrinolytic therapy, and are in cardiogenic ... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_STEMI_Immediate_(or_Emergency)_Invasive_Strategy_and_Rescue_PCI_Polling_Results_for_CLASS_IIa_Guidelines | |
f8e5d0a1e79c0aa45edf4c0796582a7883a290bb | wikidoc | Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial | Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial
September 3,2009 by Smita Kohli, M.D.
The results of the CURRENT OASIS 7(Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS) trial... | Double dose Clopidogrel associated with improved cardiac outcomes in patients undergoing PCI: Results of CURRENT/OASIS-7 Trial
September 3,2009 by Smita Kohli, M.D.
The results of the CURRENT OASIS 7(Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS) tria... | https://www.wikidoc.org/index.php/CURRENT_OASIS_7_TRIAL | |
e5d0a1e65731008e0ebf7d3676ab27bc75dae00c | wikidoc | Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery | Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery
November 7, 2007 By Scott P. Williams
Orlando, FL: The results of the POISE trial indicate that, when compared to placebo, treatment of patients with the beta-blocker metoprolol prior to and fo... | Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery
November 7, 2007 By Scott P. Williams [1]
Orlando, FL: The results of the POISE trial indicate that, when compared to placebo, treatment of patients with the beta-blocker metoprolol prior to an... | https://www.wikidoc.org/index.php/Metoprolol_Associated_with_Lower_Rates_of_Major_CV_Events_in_POISE_Trial_for_High_Risk_Patients_Undergoing_Noncardiac_Surgery | |
2b968b9fb0014736b3f8a846a2485729c8db2969 | wikidoc | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Pretreatment with amiodarone, flecainide, ibutilide, propafenone, or sotalol can be useful to enhance the success of direct-current cardioversion and prevent recurrent ... | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_enhancement_of_direct-current_cardioversion:_Polling_Results_for_CLASS_IIa_Guidelines | |
a98a6e598e2904257de5294954fe2e1d11bdf521 | wikidoc | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIb Guidelines | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. For patients with persistent AF, administration of beta blockers, disopyramide, diltiazem, dofetilide, procainamide, or verapamil may be considered, although the effica... | The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_enhancement_of_direct-current_cardioversion:_Polling_Results_for_CLASS_IIb_Guidelines | |
822e5b697ad995dfaf223f140eaf1604658380b4 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS III Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS III Guidelines
# Class III Guidelines
- Digitalis should not be used as the sole agent to control the rate of ventricular response in patients with paroxysmal AF. (Level of Evidence: B)
- Catheter ablation of... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Suggest_Revisions_to_the_CLASS_III_Guidelines | |
dc9c7c728f3cbc80e6318955a1e5ae84c6687cb2 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- A combination of digoxin and either a beta blocker or non dihydropyridine calcium channel antagonist is reasonable to control the heart rate both at rest and during exer... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
63828ec45fe651775813e846c36d2810f5ecc243 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIb Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIb Guidelines
# Class IIb Guidelines
1. When the ventricular rate cannot be adequately controlled both at rest and during exercise in patients with AF using a ], non dihydropyridine calcium channel antagonist... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Suggest_Revisions_to_the_CLASS_IIb_Guidelines | |
7071364d7d6293d236b0b6c2125e17b5154fa900 | wikidoc | Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation | Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation
About AMADEUS study
The phase III AMADEUS study was a randomised, open label trial designed to compare the efficacy and safety of once-a-week idraparinux versus oral VKA treatment for the long-t... | Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation
About AMADEUS study
The phase III AMADEUS study was a randomised, open label trial designed to compare the efficacy and safety of once-a-week idraparinux versus oral VKA treatment for the long-... | https://www.wikidoc.org/index.php/AMADEUS | |
7cafc29c38808e8d40c2de41c42644421f407bcd | wikidoc | Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial | Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial
September 24, 2009 By Alexandra M. Palmer
San Francisco, California: Results from the ISAR-DESIRE 2 trial indicate that repeat Drug-Eluting Stent (DES) implantation for DES-restenosis is safe out ... | Anti-restenotic efficacy of SES is non-superior to PES in patients with SES-restenosis: Results of the ISAR-DESIRE 2 Trial
September 24, 2009 By Alexandra M. Palmer [1]
San Francisco, California: Results from the ISAR-DESIRE 2 trial indicate that repeat Drug-Eluting Stent (DES) implantation for DES-restenosis is safe ... | https://www.wikidoc.org/index.php/Anti-restenotic_efficacy_of_SES_is_non-superior_to_PES_in_patients_with_SES-restenosis:_Results_of_the_ISAR-DESIRE_2_Trial | |
064a5d3a4f98fd36cc9598ab9cc757b61789af05 | wikidoc | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines
# Class III Guidelines
- Digoxin and sotalol may be harmful when used for pharmacological cardioversion of AF and are not recommended. (Level of Evidence: A)
- Quinidine, procainamide, disopyrami... | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see t... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_Cardioversion_of_Atrial_Fibrillation:_Suggest_Revisions_to_the_CLASS_III_Guidelines | |
0edefcc47e89ee4a9ad3fa87c200e0f25d03b852 | wikidoc | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- Administration of amiodarone is a reasonable option for pharmacological cardioversion of AF. (Level of Evidence: A)
- A single oral bolus dose of propafenone or flecainid... | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see t... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_Cardioversion_of_Atrial_Fibrillation:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
8cfb1119bb9ee56ffa0bb4b94553f15da6c92700 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Measurement of the heart rate at rest and control of the rate using pharmacological agents (either a beta blocker or non dihydropyridine calcium channel antagonist, in most ... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see t... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
0f81011470c1a919402f7b903e00d6d13ea42fc5 | wikidoc | Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT | Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT
# 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
## Recommendations for Perioperative Management–Timing of Elective Noncardi... | Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT
# 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease[1]
## Recommendations for Perioperative Management–Timing of Elective Nonca... | https://www.wikidoc.org/index.php/Recommendations_for_Perioperative_Management%E2%80%93Timing_of_Elective_Noncardiac_Surgery_in_Patients_Treated_With_PCI_and_DAPT | |
83014879eec87380e00f50ee71bda1300e4e810d | wikidoc | SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease | SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
September 1, 2008 By Alexandra M. Palmer
ESC 08-Munich, Germany: The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study failed to show that PCI is non i... | SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
September 1, 2008 By Alexandra M. Palmer [1]
ESC 08-Munich, Germany: The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study failed to show that PCI is n... | https://www.wikidoc.org/index.php/SYNTAX_study_fails_to_support_PCI_as_non-inferior_to_CABG_in_patients_with_left_main_or_3-vessel_coronary_artery_disease | |
ad097cf20243e4ba1e0c9bf91b917da73a6269e6 | wikidoc | Screening for atherosclerotic disease in other vascular beds in patient with lower extremity peripheral arterial disease | Screening for atherosclerotic disease in other vascular beds in patient with lower extremity peripheral arterial disease
# 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
# Recommendations for Screening for Atherosclerotic Disease in Other Vascular Beds for the Pati... | Screening for atherosclerotic disease in other vascular beds in patient with lower extremity peripheral arterial disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
# 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Art... | https://www.wikidoc.org/index.php/Screening_for_atherosclerotic_disease_in_other_vascular_beds_in_patient_with_lower_extremity_peripheral_arterial_disease | |
a7c252c2f8f1f9b515a947601051d1e456aa45e4 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS III Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS III Guidelines
# Class III Guidelines
1. Digitalis should not be used as the sole agent to control the rate of ventricular response in patients with paroxysmal AF. (Level of Evidence: B)
ACC / AHA 2008 guidelines ... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the ... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Polling_Results_for_CLASS_III_Guidelines | |
fd3070e3c56ca24691788383e4de65a1cc8feae1 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIa Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. A combination of digoxin and either a beta blocker or non dihydropyridine calcium channel antagonist is reasonable to control the heart rate both at rest and during exercise... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the ... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Polling_Results_for_CLASS_IIa_Guidelines | |
167020f7787e93e7db131127b02ffb9e90daac6f | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIb Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. When the ventricular rate cannot be adequately controlled both at rest and during exercise in patients with AF using a ], non dihydropyridine calcium channel antagonist, or ... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the ... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Polling_Results_for_CLASS_IIb_Guidelines | |
7b5f669fd98bf9c9f0e75b16fed6bcde360b8e3e | wikidoc | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Catheter ablation of the accessory pathway is recommended in symptomatic patients with AF who have WPW syndrome, particularly those with syncope due to rapid heart rate or those... | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the d... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Wolff_Parkinson_White_syndrome_(WPW):_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
120058ea90b1358ba3489e791b9d5bda6186ad57 | wikidoc | Guidelines for the management of aSAH (surgical and endovascular methods of treatment of ruptured cerebral aneurysms) | Guidelines for the management of aSAH (surgical and endovascular methods of treatment of ruptured cerebral aneurysms)
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
## Surgical and Endovascular Methods of Treatment of Ruptured Cerebral Aneurysms: Recommendations | Guidelines for the management of aSAH (surgical and endovascular methods of treatment of ruptured cerebral aneurysms)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage[1]
## Sur... | https://www.wikidoc.org/index.php/Guidelines_for_the_management_of_aSAH_(surgical_and_endovascular_methods_of_treatment_of_ruptured_cerebral_aneurysms) | |
454ffd19b6bcd355bca0d7d2399f2709ac3bf8e7 | wikidoc | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- Preoperative administration of amiodarone] reduces the incidence of AF in patients undergoing cardiac surgery and represents appropriate prophylactic therapy for patients at hi... | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the di... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_postoperative_atrial_fibrillation:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
ae1f2379daef2cb3ee152053c0b64fc0b4a8e0fa | wikidoc | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS IIb Guidelines | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. Administration of quinidine or procainamide might be considered for pharmacological cardioversion of AF, but the usefulness of these agents is not well established. (Level of ... | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the di... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_Cardioversion_of_Atrial_Fibrillation:_Polling_Results_for_CLASS_IIb_Guidelines | |
b3f16d64c19bff13a9bfc79084569c0353c95f43 | wikidoc | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS I Guidelines | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Measurement of the heart rate at rest and control of the rate using pharmacological agents (either a beta blocker or non dihydropyridine calcium channel antagonist, in most case... | The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the di... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_rate_control_during_atrial_fibrillation_Polling_Results_for_CLASS_I_Guidelines | |
761b8e284a10b53d31c40e7aab27a0ee75703ac2 | wikidoc | Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous | Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous
August 26, 2007 By Grendel Burrell
Despite improvement in diagnosis and treatment, as many as 18% or more of patients with suspected acute heart failure in the emergency department may be misdiagnosed (... | Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous
August 26, 2007 By Grendel Burrell [1]
Despite improvement in diagnosis and treatment, as many as 18% or more of patients with suspected acute heart failure in the emergency department may be misdiagnos... | https://www.wikidoc.org/index.php/Heart_Failure:_Acoustic_Cardiography_Improves_Clinicians%E2%80%99_Confidence_for_Making_the_Diagnosis_when_BNP_is_Ambiguous | |
0caa2d18298778133480b603d9d4a7e93ba359a0 | wikidoc | JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients | JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients
November 10, 2008 By Scott P. Williams
New Orleans, LA: The results of the JUPITER trial suggest that rosuvastatin effectively reduces the occurrence of myocardial infarction (MI), stroke, and cardiovasc... | JUPITER Trial Demonstrates Effectiveness of Statin Therapy in Reducing Cardiovascular Events among Healthy Patients
November 10, 2008 By Scott P. Williams [1]
New Orleans, LA: The results of the JUPITER trial[1] suggest that rosuvastatin effectively reduces the occurrence of myocardial infarction (MI), stroke, and car... | https://www.wikidoc.org/index.php/JUPITER_Trial_Demonstrates_Effectiveness_of_Statin_Therapy_in_Reducing_Cardiovascular_Events_among_Healthy_Patients | |
7ea45ff1d429c464684617df3c6a6164e60d427e | wikidoc | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS III Guidelines | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS III Guidelines
# Class III Guidelines
1. Intravenous administration of digitalis glycosides or non dihydropyridine calcium channel antagonists is not recommended in patients with WPW syndrome who have pre-excited ventr... | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disc... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Wolff_Parkinson_White_syndrome_(WPW):_Polling_Results_for_CLASS_III_Guidelines | |
1d2beb54f958dfdffa6eabef2c2cd17f052f397d | wikidoc | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIa Guidelines | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Intravenous flecainide or direct-current cardioversion is reasonable when very rapid ventricular rates occur in patients with AF involving conduction over an accessory pathway. ... | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disc... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Wolff_Parkinson_White_syndrome_(WPW):_Polling_Results_for_CLASS_IIa_Guidelines | |
f5a849113cca021a4ce654acbeda774d6576c5ef | wikidoc | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIb Guidelines | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. It may be reasonable to administer intravenous quinidine, procainamide, disopyramide, ibutilide, or amiodarone to hemodynamically stable patients with AF involving conduction ov... | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disc... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Wolff_Parkinson_White_syndrome_(WPW):_Polling_Results_for_CLASS_IIb_Guidelines | |
2f24a487adaf34661ddd5cee962c39894d2b44b5 | wikidoc | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Unless contraindicated, treatment with an oral beta blocker to prevent postoperative AF is recommended for patients undergoing cardiac surgery. (Level of Evidence: A)
- Administra... | The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disc... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_postoperative_atrial_fibrillation:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
9bcca97c6811c93eb1a139ee0314939fa3696d48 | wikidoc | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS I Guidelines | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Administration of flecainide, dofetilide, propafenone, or ibutilide is recommended for pharmacological cardioversion of AF. (Level of Evidence: A)
ACC / AHA 2008 guidelines for d... | The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disc... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pharmacological_Cardioversion_of_Atrial_Fibrillation:_Polling_Results_for_CLASS_I_Guidelines | |
42f5aea31e666218a43070c43610487cedbab8b0 | wikidoc | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an ... | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provi... | https://www.wikidoc.org/index.php/Dextroamphetamine_saccharate,_amphetamine_aspartate_monohydrate,_dextroamphetamine_sulfate_and_amphetamine_sulfate | |
802418faa1f2e486ed242096aa785224049bbd27 | wikidoc | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Catheter ablation of the accessory pathway is recommended in symptomatic patients with AF who have WPW syndrome, particularly those with syncope due to rapid heart rate or those wit... | The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the discla... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Wolff_Parkinson_White_syndrome_(WPW):_Polling_Results_for_CLASS_I_Guidelines | |
21c07be1471ae753dcd4b9ddddb5c67f2f20d39f | wikidoc | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Preoperative administration of amiodarone reduces the incidence of AF in patients undergoing cardiac surgery and represents appropriate prophylactic therapy for patients at high ri... | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclai... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_postoperative_atrial_fibrillation:_Polling_Results_for_CLASS_IIa_Guidelines | |
7f966dc25a9d39ff0f91f03035ac77baba605198 | wikidoc | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIb Guidelines | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. Prophylactic administration of sotalol may be considered for patients at risk of developing AF following cardiac surgery. (Level of Evidence: B)
ACC / AHA 2008 guidelines for diag... | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclai... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_postoperative_atrial_fibrillation:_Polling_Results_for_CLASS_IIb_Guidelines | |
0ed18a1d0e5c7a337452bc8267ebf06e2c259f5a | wikidoc | Class III recommendations in guidelines for cardiovascular medicine organized by year of guideline publication | Class III recommendations in guidelines for cardiovascular medicine organized by year of guideline publication
# Overview
There are 584 class III recommendations in guidelines published by American cardiology societies. Class III recommendations may be classified either by guideline name/year of publication or by reco... | Class III recommendations in guidelines for cardiovascular medicine organized by year of guideline publication
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
There are 584 class III recommendations in guidelines published... | https://www.wikidoc.org/index.php/Class_III_recommendations_in_guidelines_for_cardiovascular_medicine_organized_by_year_of_guideline_publication | |
78f17e79d137f6c3be7a462564e87997ed1ffb95 | wikidoc | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Unless contraindicated, treatment with an oral beta blocker to prevent postoperative AF is recommended for patients undergoing cardiac surgery. (Level of Evidence: A)
ACC / AHA 2008 g... | The Living Guidelines: Patients with postoperative atrial fibrillation: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaime... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_postoperative_atrial_fibrillation:_Polling_Results_for_CLASS_I_Guidelines | |
acde254b7e2887f31fcc494b593a9b81941637ae | wikidoc | Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel | Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
# Complete Title of Study
Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
# Study Acronym (The trial's abbreviation if there is one)
3T/2R
# Prin... | Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The te... | https://www.wikidoc.org/index.php/3T/2R | |
7ba72f1bd730700846f1c791463a88920bcb8889 | wikidoc | The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Direct-current cardioversion is recommended for patients with severe hemodynamic compromise or intractable ischemia, or when adequate rate control cannot be achieved with pharmacological... | The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimer... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_acute_myocardial_infarction:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
efccccc413a5d9bcb89f1e6100516eea677f6fe8 | wikidoc | Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents
# Overview
Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, despite compliance with lifestyle recommendations.
... | Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, ... | https://www.wikidoc.org/index.php/Hyperlipidemia_NCEP_recommendations_for_drug_therapy_of_high-risk_hyperlipidemia_in_children_and_adolescents | |
5dcf187e6bb1e9c7f5a552eecbf3d083bc5686a9 | wikidoc | The Living Guidelines: Summary of the Current Recommendations for Percutaneous Coronary Interventions (PCI) | The Living Guidelines: Summary of the Current Recommendations for Percutaneous Coronary Interventions (PCI)
# Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI)
## Class I
1. An early invasive PCI strategy is indicated for patients with UA/NSTEMI who have n... | The Living Guidelines: Summary of the Current Recommendations for Percutaneous Coronary Interventions (PCI)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Cafer Zorkun, M.D., Ph.D. [2]
# Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI)
## Class I
1... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Summary_of_the_Current_Recommendations_for_Percutaneous_Coronary_Interventions_(PCI) | |
fe340705d3827dfe35077dd1a32b50058dc08e5f | wikidoc | Exercise Tolerance Test Time as an Endpoint for Clinical Trials Evaluating Therapies for Refractory Angina | Exercise Tolerance Test Time as an Endpoint for Clinical Trials Evaluating Therapies for Refractory Angina
To read more about "Exercise stress testing", click here.
# Overview
For many years, cardiac stress testing has played an important role in evaluating patients with heart disease. The concept behind exercise str... | Exercise Tolerance Test Time as an Endpoint for Clinical Trials Evaluating Therapies for Refractory Angina
Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Ernest Gervino, M.D.; Donald E. Cutlip, M.D.
To read more about "Exercise stress testing", click here.
# Overview
For many years, cardiac... | https://www.wikidoc.org/index.php/Exercise_Tolerance_Test_Time_as_an_Endpoint_for_Clinical_Trials_Evaluating_Therapies_for_Refractory_Angina | |
3f261c720546b59a486963ff138e852744f7e5bc | wikidoc | High red cell distribution width associated with adverse outcomes in patients with coronary artery disease | High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
January 6, 2008 By Benjamin A. Olenchock, M.D. Ph.D. Alberta
The red cell distribution width (RDW) is a measure of the variability of size in the red cell population. It is a numerical measure of anisocytosis, c... | High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
January 6, 2008 By Benjamin A. Olenchock, M.D. Ph.D. [1] Alberta
The red cell distribution width (RDW) is a measure of the variability of size in the red cell population. It is a numerical measure of anisocytosi... | https://www.wikidoc.org/index.php/High_red_cell_distribution_width_associated_with_adverse_outcomes_in_patients_with_coronary_artery_disease | |
a672895f018d24eab45f1d7466b25bb198f2c20e | wikidoc | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS III Guidelines | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS III Guidelines
# Class III Guidelines
- Theophylline and beta-adrenergic agonist agents are not recommended in patients with bronchospastic lung disease who develop AF. (Level of Evidence: C)
- Beta blockers, sotalol, propafen... | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers p... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Pulmonary_Hypertension:_Suggest_Revisions_to_the_CLASS_III_Guidelines | |
46677187e9bf8f2e98da76112bf53e9fa31c7c11 | wikidoc | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS III Guidelines | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS III Guidelines
# Class III Guidelines
1. The administration of class IC antiarrhythmic drugs is not recommended in patients with AF in the setting of acute MI. (Level of Evidence: C)
ACC / AHA 2008 guidelines for diagnosis and... | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers p... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_acute_myocardial_infarction:_Polling_Results_for_CLASS_III_Guidelines | |
7ab43df266103a2befcd951230f2c744c867b450 | wikidoc | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Intravenous administration of digitalis is reasonable to slow a rapid ventricular response and improve LV function in patients with acute MI and AF associated with severe LV dysfunction ... | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers p... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_acute_myocardial_infarction:_Polling_Results_for_CLASS_IIa_Guidelines | |
e3388a9785fada98baadbc381cd5b37ac4d82697 | wikidoc | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Antiarrhythmic medications can be useful to prevent recurrent AF in patients with hypertrophic cardiomyopathy. Available data are insufficient to recommend one agent over another in this... | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers p... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_hypertrophic_cardiomyopathy:_Polling_Results_for_CLASS_IIa_Guidelines | |
a8f730616f13d5ebfe01dcc1e71c7e8c9156dfc7 | wikidoc | ACR practice guideline for the performance and interpretation of cardiac magnetic resonance imaging (MRI) | ACR practice guideline for the performance and interpretation of cardiac magnetic resonance imaging (MRI)
Adapted from the American College of Radiology's Practice Guideline for the Performance and Interpretation of Cardiac Magnetic Resonance Imaging (MRI), 2006, Effective 10/01/06acrcmr
# Introduction
## Important A... | ACR practice guideline for the performance and interpretation of cardiac magnetic resonance imaging (MRI)
Template:WikiDoc Cardiology News
Editor in Chief: Evan Appelbaum, MD [1]
Adapted from the American College of Radiology's Practice Guideline for the Performance and Interpretation of Cardiac Magnetic Resonance Ima... | https://www.wikidoc.org/index.php/ACR_Practice_Guideline_for_the_Performance_and_Interpretation_of_Cardiac_Magnetic_Resonance_Imaging_(MRI) | |
0c9784f22fd763dad9a92a71de165e72149893c4 | wikidoc | Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes | Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
Synonyms and keywords: Apo A-1 Milano, ETC 216, MDCO 216
# Official Title
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial
#... | Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Rim Halaby, M.D. [2]
Synonyms and keywords: Apo A-1 Milano, ETC 216, MDCO 216
# Official Title
Effect of recombinant ApoA-I Mila... | https://www.wikidoc.org/index.php/Apo_A-1_Milano | |
af5d9b3a057fe132a598c3b3413b45759f374b39 | wikidoc | ST Elevation Myocardial Infarction Inhibition of the Renin-Angiotensin-Aldosterone System as Initial Care | ST Elevation Myocardial Infarction Inhibition of the Renin-Angiotensin-Aldosterone System as Initial Care
# Overview
# Guidelines (Do not edit)
# Sources
- The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
- The 2007 Focused Update of the ACC/AHA 2004 Guidelines for... | ST Elevation Myocardial Infarction Inhibition of the Renin-Angiotensin-Aldosterone System as Initial Care
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
# Guidelines (Do not edit) [1][2]
# Sources
- The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [1]... | https://www.wikidoc.org/index.php/ST_Elevation_Myocardial_Infarction_Inhibition_of_the_Renin-Angiotensin-Aldosterone_System_as_Initial_Care | |
07699730601c6db2533e4fe2837c8b510dbd61b0 | wikidoc | Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension | Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
# Complete Title of Study
A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity ... | Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
# Complete Title of Study
A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity ... | https://www.wikidoc.org/index.php/ACCOMPLISH | |
8c7dcbe7811c21c471524cce9d2d9e3836f50b58 | wikidoc | Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up | Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up
March 29, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL:: An analysis from the National Cardiovascular Data Registry demonstrates that percutaneous coronary intervention (PCI) can be performed safely and successfu... | Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up
March 29, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL:: An analysis from the National Cardiovascular Data Registry demonstrates that percutaneous coronary intervention (PCI) can be performed safely and successf... | https://www.wikidoc.org/index.php/Percutaneous_Coronary_Interventions_can_be_performed_in_centers_without_on-site_cardiac_surgical_back-up | |
67078410150b1c63c0f1a80a12e3ac8a5d1bd51d | wikidoc | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Correction of hypoxemia and acidosis is the recommended primary therapeutic measure for patients who develop AF during an acute pulmonary illness or exacerbation of chronic pulmonary disease.... | The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers pag... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Pulmonary_Hypertension:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
0cf459803da274a12b56534f2788cea1962edeb3 | wikidoc | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Direct-current cardioversion is recommended for patients with severe hemodynamic compromise or intractable ischemia, or when adequate rate control cannot be achieved with pharmacological age... | The Living Guidelines: Patients with acute myocardial infarction: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers pag... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_acute_myocardial_infarction:_Polling_Results_for_CLASS_I_Guidelines | |
ce9ed42b16c30aedcc31f088240939fc6fceb9df | wikidoc | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Oral anticoagulation (INR 2.0 to 3.0) is recommended in patients with hypertrophic cardiomyopathy who develop AF, as for other patients at high risk of thromboembolism. (Level of Evidence: B... | The Living Guidelines: Patients with hypertrophic cardiomyopathy: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers pag... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_hypertrophic_cardiomyopathy:_Polling_Results_for_CLASS_I_Guidelines | |
c34852adb543fe0960d77d34e09ab1d10738e363 | wikidoc | Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial | Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial
September 3, 2009 by Katherine Ogando
ESC Congress 2009- Barcelona, ES: Among patients with atrial fibrillation (AF), dabigatran is non-inferior to warfarin in lowering the risk of stroke and systemic embolism, accor... | Dabigatran is non-inferior to warfarin in patients with atrial fibrillation: Results of the RE-LY trial
September 3, 2009 by Katherine Ogando
ESC Congress 2009- Barcelona, ES: Among patients with atrial fibrillation (AF), dabigatran is non-inferior to warfarin in lowering the risk of stroke and systemic embolism, acco... | https://www.wikidoc.org/index.php/Dabigatran_is_non-inferior_to_warfarin_in_patients_with_atrial_fibrillation:_Results_of_the_RE-LY_trial | |
3e9f714d768dde98fe0a9c0ede352f812b2543d2 | wikidoc | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS III Guidelines | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS III Guidelines
# Class III Guidelines
1. Theophylline and beta-adrenergic agonist agents are not recommended in patients with bronchospastic lung disease who develop AF. (Level of Evidence: C)
ACC / AHA 2008 guidelines for diagnosi... | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS III Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page f... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Pulmonary_Hypertension:_Polling_Results_for_CLASS_III_Guidelines | |
82419d4dc52f990e0748ee1622b62e2c9bda6846 | wikidoc | Class III recommendations in guidelines for cardiovascular medicine organized by guideline keywords | Class III recommendations in guidelines for cardiovascular medicine organized by guideline keywords
# Overview
There are 584 class III recommendations in guidelines published by American cardiology societies. Class III recommendations may be classified either by guideline name/year of publication or by recommendation ... | Class III recommendations in guidelines for cardiovascular medicine organized by guideline keywords
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
There are 584 class III recommendations in guidelines published by America... | https://www.wikidoc.org/index.php/Class_III_recommendations_in_guidelines_for_cardiovascular_medicine_organized_by_guideline_keywords | |
af61fdfb6abb1ca90001d60f367cb89e8877e8ea | wikidoc | L-transposition of the great arteries or congenitally corrected transposition of the great arteries | L-transposition of the great arteries or congenitally corrected transposition of the great arteries
# Overview
# Classification
# Pathophysiology
# Causes
# Differentiating Levo-transposition of the great arteries from other Diseases
# Epidemiology and Demographics
# Natural History, Complications and Prognosis
... | L-transposition of the great arteries or congenitally corrected transposition of the great arteries
Template:DiseaseDisorder infobox
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri S... | https://www.wikidoc.org/index.php/L-TGA | |
a948f1dd8ceede3f460e66edffb25e8032cc49d7 | wikidoc | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Correction of hypoxemia and acidosis is the recommended primary therapeutic measure for patients who develop AF during an acute pulmonary illness or exacerbation of chronic pulmonary disease. (Le... | The Living Guidelines: Patients with Pulmonary Hypertension: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_Pulmonary_Hypertension:_Polling_Results_for_CLASS_I_Guidelines |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.